I am glad to roll out to you a few photographs of the event, with the permission of the organizers. Please click here to view the pictures and register your comments.
I am proud to announce that Oviya MedSafe has launched comprehensive cost-effective pharmacovigilance service packages for the 'Rest of the World' (RoW) region. The term RoW region, traditionally meant to refer to the countries in the Asia Pacific, Latin American, Eastern Europe, African and Middle East regions, is a very important market for exporters of pharmaceutical products and medical devices globally, in terms of business expansion and revenue. The need for pharmacovigilance compliance in the RoW region assumes more significance as the demand for harmonisation and implementation of regulations is growing across all markets.
Under these packages, in addition to offering outsourced drug safety support to pharmaceutical companies and marketing authorization holders, Oviya MedSafe will render pharmacovigilance consulting support to the regulatory agencies and the pharmaceutical industry in the RoW region. I would like to thank all the pharmaceutical industry magazines and portals which have patronized this news with great interest. Please click on the names of the respective magazines / portals to read the detailed news reports they published in this regard: Express Pharma, Pharma Asia, Pharmabiz and Life Science World.
Oviya MedSafe's partnership with UK-based software company Assured Information Systems, to use and promote the use of their hosted pharmacovigilance software database PV247 in India and the overall Asia Pacific region, has come a long way since its beginning in April 2014. The first webinar that Oviya MedSafe and Assured Information Systems jointly organized on 10-Sep-2014 was well-attended and included a free demonstration of the PV247 system which sensitized the industry about the multiple benefits of adopting a robust hosted pharmacovigilance system while allaying the unreasonable fears linked to its perceived risks.
We understand that we would have to organize these webinars and demonstration sessions more frequently in order to clear our waiting list of requests for such sessions which have originated from our colleagues in the industry across the globe. In acceptance of these requests, Oviya MedSafe, along with Assured Information Systems, will facilitate a free one hour webinar session titled 'Assuring Cost Effective Global Pharmacovigilance Compliance' on Wednesday, 03-Dec-2014 from 3 PM to 4 PM Indian Standard Time (9:30 AM to 10:30 AM Greenwich Mean Time). This webinar would include a free demonstration of the PV247 system and has been tailored exclusively for pharmaceutical companies and marketing authorization holders located in India, Europe, CIS, MENA & APAC.
Please confirm your interest in registering for this free webinar by sending an e-mail to email@example.com with your name, designation, e-mail address and the name of your organisation. You will receive the confirmation of your registration and call-in details for the webinar subsequently.
As you might already know, Oviya MedSafe is the Bronze Partner for the 7th Pharmacovigilance 2014 conference organized by Virtue Insight on Friday, November 21, 2014 at Kohinoor Continental Hotel, Mumbai, India. This is our third consecutive bronze partnership with Virtue Insight after our participation in their previous events in Mumbai in 2013 and London in early 2014. I take this opportunity to invite you to visit us at our stall in the conference.
Before signing off, I am pleased to mention that the Indian Society for Clinical Research has planned to organize a Pharmacovigilance Symposium titled ‘Comprehensive Pharmacovigilance for India – The Road Ahead’ in Peninsula Grand Hotel at Mumbai on 20-Dec-2014. I request you to keep a watch on ISCR website periodically for the detailed agenda and seek your active participation in large numbers to make this event a grand success.
Looking forward to writing to you in December 2014 with news of further interest,
With thanks & regards,
Dr J Vijay Venkatraman
MBBS, F. Diab., MBA
Managing Director & CEO,
Pharmacovigilance Consulting & Drug Safety Services
Coimbatore, India & London, UK
India Office: +91-422-2444442
UK Office: +44-8452-733839